Cardiomyocyte‐Specific Telomere Shortening is a Distinct Signature of Heart Failure in Humans. Issue 9 (7th September 2017)

• Record Type: Journal Article
• Authors: Sharifi‐Sanjani, Maryam; Oyster, Nicholas M.; Tichy, Elisia D.; Bedi, Kenneth C.; Harel, Ofer; Margulies, Kenneth B.; Mourkioti, Foteini
• Is Part Of: Journal of the American Heart Association. Volume 6:Issue 9(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-09-07
• Subjects: cardiomyocyte -- cardiomyopathy -- telomere length; Heart -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cerebrovascular disease -- Periodicals; Cardiology -- Periodicals; 616.1
• DOI: 10.1161/JAHA.116.005086
• Languages: English
• ISSNs: 2047-9980

Abstract

Abstract : Background: Telomere defects are thought to play a role in cardiomyopathies, but the specific cell type affected by the disease in human hearts is not yet identified. The aim of this study was to systematically evaluate the cell type specificity of telomere shortening in patients with heart failure in relation to their cardiac disease, age, and sex. Methods and Results: We studied cardiac tissues from patients with heart failure by utilizing telomere quantitative fluorescence in situ hybridization, a highly sensitive method with single‐cell resolution. In this study, total of 63 human left ventricular samples, including 37 diseased and 26 nonfailing donor hearts, were stained for telomeres in combination with cardiomyocyte‐ or α‐smooth muscle cell‐specific markers, cardiac troponin T, and smooth muscle actin, respectively, and assessed for telomere length. Patients with heart failure demonstrate shorter cardiomyocyte telomeres compared with nonfailing donors, which is specific only to cardiomyocytes within diseased human hearts and is associated with cardiomyocyte DNA damage. Our data further reveal that hypertrophic hearts with reduced ejection fraction exhibit the shortest telomeres. In contrast to other reported cell types, no difference in cardiomyocyte telomere length is evident with age. However, under the disease state, telomere attrition manifests in both young and older patients with cardiac hypertrophy. Finally, we demonstrate that cardiomyocyte‐telomere length is better sustained in women than men under diseased conditions. Conclusions: This study provides the first evidence of cardiomyocyte‐specific telomere shortening in heart failure.